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An  antigen  that  clearly marked T  helper cells was  first identified when  the 
W3/25 mouse monoclonal antibody was raised against rat thymocytes (1, 2). The 
W3/25  antigen  appears  to be equivalent  to  human  T4  antigen,  which  is  now 
called CD4 (3), and to mouse L3T4 antigen (4-6).  Henceforth, we will call the 
rat antigen  "CD4 (W3/25)."  Antibodies to CD4  antigens  inhibit T  helper cell 
responses  in  vitro  (5,  7,  8)  and  the  CD4  molecule  has  been  sugested  as  a 
recognition structure for class II antigens (5, 9,  10). 
Since the CD4 (W3/25) antigen seemed to have an important role in T  helper 
cell responses (7, 8), it was a surprise when Barclay (11) showed that the W3/25 
antibody  labeled  rat  peritoneal  macrophages.  In  humans,  anti-T4  antibodies 
have  also  been  shown  to  label  macrophages  (12,  13).  However,  thus  far  the 
molecular characteristics of the CD4 antigens from macrophages have not been 
established  in  any  species.  In  this  paper  we  examine  this  point  to  determine 
whether rat macrophages express authentic CD4 (W3/25) antigen. 
Materials and Methods 
Animals.  BALB/c mice  (H-2  a)  and  congenitally athymic PVG  (rnu/rnu)  rats  were 
obtained from Olac (1976), Ltd. (Bicester, Great Britain). Specific pathogen-free inbred 
rats, PVGoRT I c and DA-RT I a (PVG and DA), were from the MRC Cellular Immunology 
Unit, Oxford. 
Antibodies.  Hybridomas were produced by fusing mouse spleen cells and the mouse 
myeloma cell lines NS1/1.Ag 4.1  (MRC OX-27 and OX-37), P3-X63/Ag 8 (MRC OX- 
38),  or  NSO/1  (MRC  OX-34,  -35,  -36)  as  described  (14).  The  antibodies  used  are 
summarized in Table I. Those not previously described are: MRC OX-27 was prepared 
by  Dr.  M.  Brandon  after immunization  of mice  with  phytohemagglutinin blasts  and 
resulted from  fusion as  described (20);  MRC  OX-34,  -35,  -36  were  prepared  by  M. 
Puklavec, J.  Green, and W. Jefferies after immunizing mice with T  blasts  prepared in 
mixed lymphocyte reactions with purified rat T  helper cells against irradiated spleen (8); 
and MRC OX-37 and MRC OX-38 from fusions carried out by M. Puklavec and Drs. G. 
Woollett and M.  Dallman, respectively, with mice immunized with lymphocytes or thy- 
mocyte glycoproteins as in previous studies (17, 21). Other antibodies used were purified 
rabbit anti-mouse IgG antibody and its F(ab')2 fragment and purified F(ab')~ anti-mouse 
Fab (22). 
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TABLE  I 
Monoclonal Antibodies and Their Reactivity With Rat Tissue 
Antibody  Specificity  Subclass  Reference 
W3.25  Rat CD4 antigen  IgG1  1 
MRC OX-35  Rat CD4 antigen  IgG2a  See Materials and Methods 
OX-36  IgG2a 
OX-37  IgG1 
OX-38  IgG2a 
MRC OX-6  Rat MHC class II, I-A  IgG1  15 
MRC OX-12  Rat kappa  IgG2a  16 
W3/13  LSGP,* pan T, polymorphs, not B  IgG1  1 
MRC OX-19  Pan T, rat Ly-1 equivalent  lgG1  17 
MRC OX-21  Human C3b inactivator  IgG1  18 
MRC OX-27  Rat MHC class I, C haplotype  IgG2a  Materials and Methods 
W6/32  Human HLA, A, B, C  IgG2a  19 
MRC OX-34  Pan T, other leukocytes, not B  IgG2a  Materials and Methods 
* Leukocyte sialoglycoprotein. 
Lymphocytes.  Thoracic duct lymphocytes (TDL) ~ were collected overnight at 4°C  in 
Dulbecco's A  plus B  medium (DAB) containing 20  U/ml heparin. T  cells were obtained 
from  PVG TDL after rosette depletion with  MRC  OX-12  antibody to remove B  cells 
(23). Other cells were washed and prepared by standard methods (24). 
Peritoneal Macrophages.  PVG rats were killed by cervical dislocation under anesthetic 
and  15  ml of buffer containing phosphate-buffered saline (PBS),  10%  DA serum, and  1 
U  heparin  per  milliliter was  injected intraperitoneally into  each  rat  and  subsequently 
removed with a Pasteur pipette. The cells were washed twice in DAB, 5% DA serum and 
kept at 4°C. To enrich for macrophages the peritoneal cells (1.5-2 ×  l0  s) were incubated 
for  1 h  at 4°C  with a  mixture of tissue culture supernatants containing the monoclonal 
antibodies W3/13, MRC OX-6, MRC OX-34, and MRC OX-19, and 10% DA serum (see 
text and Table I for antibody specificities). After washing, the cells were incubated for 20 
rain at 4°C with sheep red blood cells coated with F(ab')~ anti-mouse IgG antibody (23) 
and the cell suspension was layered over 2 ml of 20% (wt/vol) metrizamide (Nyegaard & 
Co., Oslo) in PBS, 0.2% bovine serum albumin (BSA) and centrifuged for 10 rain at 600 
g at 4°C. The nonrosetted cells were found at the interface and were collected and washed 
in PBS, 0.2%  BSA. 25%  of the starting cells were recovered and, of these, >80%  were 
phagocytic as judged by their ability to ingest latex particles. 
Labeling of Cells with Antibodies.  Cells were labeled with saturating levels of monoclonal 
antibodies followed by fluorescein isothiocyanate (FITC)-labeled F(ab')2 anti-mouse IgG 
antibody, and binding was analyzed on a  FACS II (Becton,  Dickinson & Co., Salt Lake 
City, UT) (2). 
Biosynthetic and Surface Labeling  of CeUs and Immunoprecipitation.  2.7  x  107  purified 
peritoneal macrophages were labeled with 1.25 mCi [~sS]-L-methionine or [35S]-L-cysteine 
(Amersham International Ltd., Amersham, Great Britain) for  16  h  at 37°C  in 5  mi of 
methionine- or cysteine-free Eagle's medium  containing  10%  dialyzed fetal calf serum 
(FCS). The number of cells recovered after incubation was roughly equal to those added 
and the viability was 60-95% in different experiments. For surface labeling with 125I, 2 × 
Abbreviations used in this paper:  ~2m, 132  microglobulin; BSA,  bovine serum albumin;  DAB, 
Dulbecco's A plus B medium; FACS, fluorescence-activated cell sorter; FCS, fetal calf serum; FITC, 
fluorescence isothiocyanate; MHC, major histocompatibility complex; PBS, phosphate-buffered sa- 
line; SDS-PAGE~ sodium dodecyl sulphate-polyacrylamide  gel electrophoresis; TDL, thoracic duct 
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10  7 cells  were  washed  in  Dulbecco's  modified  Eagle's  medium  and  incubated  with 
lactoperoxidase, glucose  oxidase,  and  1 mCi  Nat~SI (Amersham  International  Ltd.)  as 
described (25). 
Labeled cells were solubilized in DAB plus  1% Brij 96 or 1% Nonidet P-40; immuno- 
precipitations were carried out as described (6) after adding monoclonal  antibody and 
then protein A-Sepharose 4B beads with bound rabbit anti-mouse IgG. Precipitates  were 
analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) fol- 
lowed by fluorography for [35S]methionine or [3~S]cysteine  and autoradiography for l~sI. 
Results 
New Antibodies  to  Rat  CD4  0413/25) Antigen  and  an Antibody  to  a  Rat Pan  T 
Antigen.  The monoclonal antibodies MRC OX-35 through  38 were judged to 
be against the CD4 (W3/25) antigen on the basis of their pattern of cell labeling 
and  immunoprecipitation  data.  On  TDL  all  the  antibodies  gave  the  labeling 
pattern as shown for W3/25 and MRC OX-35 antibodies in Fig.  1A. In experi- 
ments to test for competitive binding it was found that, when W3/25 and MRC 
OX-37 or OX-38 antibodies were mixed together, the binding was indistinguish- 
able from either antibody alone (data not shown); thus, these antibodies reacted 
with an identical  or adjacent antigenic site.  In contrast,  W3/25 and MRC OX- 
35 or OX-36 antibodies were noncompetitive in binding, as can be seen in Fig. 
1 A, which shows additive binding when the antibodies were mixed together. 
MRC OX-35 through OX-38 antibodies all precipitated bands from detergent 
extracts of ~25I-labeled  thymocytes that were indistinguishable from the material 
immunoprecipitated  with  W3/25  antibody.  This  is  illustrated  by  the  results 
obtained with W3/25 and MRC OX-35 antibodies (Fig.  2, lanes 3 and 4). That 
all antibodies bound to the same antigen was shown by the results obtained by 
passing detergent extracts from  ~25I-labeled  thymocytes through a  W3/25 anti- 
body affinity column. This removed material that could be immunoprecipitated 
by the noncompetitive antibody MRC OX-35 as well as by W3/25 antibody (Fig. 
2, lanes 7 and 8). 
The MRC OX-34 antibody labeled more TDL than did W3/25 antibody (Fig. 
1 A) and was found to bind to all peripheral  T  cells and most thymocytes. This 
antibody was of interest because it did not label peritoneal  macrophages (e.g., 
Fig.  1 C) and thus could be used as a  control to detect T  cell contamination  in 
experiments with antibodies against CD4 (W3/25) antigen. Although MRC OX- 
34 did not label peritoneal macrophages, it was not T  cell specific, since many as 
yet undefined cells were labeled using the immunoperoxidase method on sections 
from rat  spleen  (data  not shown).  The  thymocyte molecule detected by MRC 
OX-34 antibody had a molecular weight of ~52,000 (Fig. 2, lanes 2 and 6) and 
was not depleted from extracts that passed through  a  W3/25 antibody affinity 
column (Fig. 2, lane 6). 
Functional effects of the new antibodies were tested by adding antibody in the 
form of tissue culture supernatants  to in vitro cultures and stimulating  lympho- 
cyte division by allogeneic cells or concanavalin A. All the new antibodies against 
the  CD4  (W3/25)  antigen  inhibited  mixed  lymphocyte  responses  by 90%  at 
dilutions  of tissue  culture  supernatant  up  to  1:90.  This  result  is  the  same as 
previously reported  for  the  W3/25  antibody  (7,  8)  and,  in  addition,  the  new 120 
l 
i 
m, 
i 
0 
(A) 
AUTHENTIC  CD4  (W3/25)  ANTIGEN  ON  MACROPHAGES 
T~  (S)  PERITONEAL  CELLS  (C)  PERITONEAL  CELLS  FROM 
FROM  NORMAL  RATS  ATHYMIC  AND  NORMAL  RATS 
,-,t  ,..,,i  e"  .....  ,,i.,. 
Wl#ll  I-OEPL~I  LAmEUIAI  ATHYMIC  Wl#16 
I  OX-I  ll-~l~OM  I  OX-II  lllll  IG  OX-ll 
I ',LJ'"tt,221  .........  :°" 5. 
W~+~  OX-81  POIT-OE~ET~  Wllie  NORMAL  W$/16 
MAC OX-~  IOIY-I~IT~N  I¢  O/-il  IlL  MAC 01-18 
t 
......  _  331 
MmG  01-il  POST-DEPLET~N  RAM  ATHy~  ~RG  0X-$4 
FLUORE~ENCE  (L~EAR)  ~", 
FIC.VRE  1.  Labeling of TDL  and normal and athymic peritoneal macrophages. Cells were 
labeled  with  monoclonal  antibodies in  the  form  of tissue culture  supernatant followed  by 
FITC-rabbit F(ab')~ anti-mouse IgG with both steps at 4°C.  Fluorescence histograms were 
obtained on the FACS with 105 cells counted for each profile. The value for the percent cells 
labeled with fluorescence greater than the marker is given above each profile and the antibodies 
are indicated below in each case. The MRC OX-21 (IgG1) antibody was used as a nonspecific 
control and similar control profiles were seen when the W6/32 (IgG2a) control antibody was 
used.  The profiles are (A) for labeled TDL, (B) for macrophage-enriched populations from 
the  peritoneum  of normal  rats,  and  (C)  for  unfractionated  macrophages  from  normal  or 
athymic rats.  In B,  pre-depletion  labeling included addition of MRC  OX-6,  MRC  OX-19, 
MRC OX-34, and W3/13  antibodies in the first step; the post-depletion RAM profile is for 
cells incubated with FITC-rabbit F(ab')~ anti-mouse IgG only after the cells labeled with the 
antibody cocktail had been removed by rosette depletion. The last profile in C shows labeling 
with MRC OX-34 antibody and a similar profile was seen with MRC OX-19 antibody (1.2% 
labeled) and MRC OX-21 (1.3% labeled). 
antibodies  matched the W3/25  antibody in  having no effect on proliferation 
stimulated by concanavalin A. 
Labeling of Macrophages.  Resident peritoneal cells from normal animals in- 
clude -75% macrophages of which ~ 10% are activated as assessed by expression 
of Ia antigen (11). In our experiments the following unwanted cells were removed 
from  the  peritoneal  cell  population  by  rosette  depletion  after  labeling  with 
appropriate antibodies (see Table I): B cells and Ia  + macrophages (MRC OX-6 
antibody), T  cells (MRC OX-19,  OX-34, and W3/13  antibodies), and granulo- 
cytes (W3/13 antibody). The labeling of peritoneal cells with the above antibody 
cocktail  before and  after  depletion  is  shown  in  Fig.  1  B  in  the  first  and  last 
profiles. >80% of the recovered cells were able to ingest latex beads and >90% 
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125  FmURE 2.  12% SDS-PAGE of  I-labeled  thymocyte glycoproteins passed through MRC 
8  125  OX-1 or W3/25 affinity columns. 10  thymocytes were labeled with Na  I by the lactoper- 
oxidase, glucose oxidase method. The membrane proteins were solubilized  in 4 ml 1% Brij 96 
and, after centrifugation,  1.9 ml of extract was passed through either MRC OX-1 or W3/25 
affinity columns (5 ml of 10 mg IgG per milliliter Sepharose 4B) with the MRC OX-1 column 
being used as a  control,  lmmunoprecipitation  was carried  out using the material passing 
through the columns with the monoclonal antibodies: MRC OX-1 (lanes I and 5), MRC OX- 
34 (2 and 6), W3/25 (3 and 7), MRC OX-35 (4 and 8). All samples were reduced with 5% 2- 
mercaptoetbanol. 
antigen, as shown for W3/25 and MRC OX-35 antibodies (Fig. 1 B). The labeling 
could  not  be  due  to  Fc  receptors  since  incubation  with  control  antibodies  of 
subclass  IgG1  (MRC  OX-21)  (Fig.  1B) or IgG2a (W6/32)  (not shown) labeled 
only a  small percentage of the cells. 
Peritoneal cells from athymic rats were studied  to test whether the presence 
of CD4 (W3/25) antigen on macrophages depended upon T  cells. The cells from 
athymic rats were used  without macrophage enrichment procedures.  It can be 
seen in Fig.  1 C that W3/25 and MRC OX-35 antibodies each label ~75% of the 
peritoneal  ceils and  that  the  labeling  was  similar  to  that  seen  with  cells  from 
normal rats (Fig. 1 C). The MRC OX-19 and OX-34 antibodies that label T  cells, 
however, labeled only 2% more athymic peritoneal cells than a control antibody 
(see legend to Fig.  1 C). 
Molecular Forms of CD4 (W3/25) Antigen on Macrophages.  T  cells and macro- 
phages purified with rosetting techniques were surface labeled with 1251 and the 
CD4 (W3/25) antigen was immunoprecipitated from detergent extracts prepared 
from the cells.  Fig.  3  shows that a  molecule with the same molecular form was 
precipitated from both cell types. From T  cells, W3/25 antibody precipitated a 
band at 46,000 mol wt in the unreduced form (Fig. 3, lane 2) and at 53,000 mol 
wt in the reduced form (Fig.  3, lane 8). The shift in apparent molecular weight 
upon reduction can be clearly seen in comparison with the band precipitated by 
MRC OX-34 antibody (Fig.  3,  lanes 3  and 9), which has a  molecular weight of 
~52,000  regardless  of  reduction.  From  macrophages,  the  W3/25  antibody 122  AUTHENTIC  CD4  (W3/25)  ANTIGEN  ON  MACROPHAGES 
FIGURE 3.  15% SDS-PAGE of 12~l-labeled purified T  cells and peritoneal macrophages (M~b). 
After solubilization in  1%  Nonidet P-40, immunoprecipitation was carried out with control 
antibody MRC OX-21  (1,  4,  7,  and 10),  W3/25 (2, 5,  8, and 11), or MRC OX-34 (3,  6,  9, 
and 12). Lanes 1-6 were run nonreduced and 7-12,  reduced, with 5% 2-mercaptoethanol. 
precipitated a band with identical mobility to the T  cell product in the unreduced 
and  reduced  state  (Fig.  3,  lanes  5  and  11). No  band  was  precipitated  from 
macrophages with the  MRC OX-34 antibody (Fig.  3,  lanes 6 and  12) or MRC 
OX-19 antibody (data not shown) and this confirms the absence of contaminating 
T  cells in the macrophage preparation. 
The CD4 (W3/25) antigen  was also immunoprecipitated from peritoneal cells 
of athymic rats and again a band of the predicted size was found (Fig. 4, lanes 2 
and 4). In this case the cells were used without depletion but this does not affect 
interpretation  of the  results  since significant  numbers  of T  cells could not be 
detected amongst the peritoneal cells of athymic rats (Fig.  1 C, last profile). 
In  an  attempt  to  prove  endogenous  synthesis  of CD4  (W3/25)  antigen  by 
macrophages,  we  labeled  purified  preparations  of normal  peritoneal  macro- 
phages with  [~SS]cysteine  or  [~SS]methionine.  Despite background  problems in 
some experiments, a specific band was consistently seen at the molecular weight 
for CD4 (W3/25) antigen;  one result for unreduced material is shown in Fig. 5, 
in which lane 2 shows material precipitated with W3/25 antibody. However, this 
band, which was observed in six experiments, was always at low intensity, as seen 
by comparing  it with  material  precipitated  with  MRC  OX-27  antibody,  which 
reacts  with  rat  class  I  antigen  (Fig.  5,  lane  3).  In  contrast,  the  CD4  (W3/25) 
antigen on T  cells was quite well labeled in comparison with class I antigen (data 
not shown).  An  additional  problem  in  metabolic  labeling experiments  was the 
fact that the MRC OX-34 antigen did not provide an effective control for T  cell 
contamination  because  of  low  incorporation  of either  [~5S]cysteine  or  [~5S]- JEFFERIES,  GREEN,  AND  WILLIAMS  123 
FIGURE 4.  10%  SDS-PAGE of ~251-1abeled peritoneal  macrophages  from nude  rats.  After 
solubilization in 1% Nonidet P-40 immunoprecipitation was with control antibody MRC OX- 
21  (1  and  3) and W3]25  antibody (2 and  4).  Lanes  1 and  2  are nonreduced and 3  and  4, 
reduced, using 5% 2-mercaptoethanol. 
methionine into  this  band.  Thus,  the  metabolic labeling experiments did  not 
provide conclusive evidence for endogenous synthesis of CD4 (W3/25) antigen 
by macrophages. 
Finally, one previously unreported result concerning the molecular form of 
CD4 (W3/25) antigen was seen after surface labeling with ~esI material. This was 
the presence of an apparently specific band at  11,500  mol wt, unreduced, and 
13,000,  reduced, that was precipitated by antibodies against the CD4 (W3/25) 
antigen. This band was seen in immunoprecipitation from T  cells (Fig. 3, lanes 
2  and  8)  and  macrophages  (Fig.  3,  lanes  5  and  11;  poorly  shown  in  this 
photograph but visible in the radiographs). The band was not/32-microglobulin 
(/32m), since it did not coincide with the/32m band from rat class I antigen when 
compared with the CD4  (W3/25)  antigen on the same gels (data not shown). 
Also,  the  low  molecular weight  band  could  not  be  convincingly detected in 
metabolic labeling experiments using T  cells or macrophages. Furthermore, in 
structural studies on the rat CD4  (W3/25)  antigen (W. Jefferies, unpublished 
results), the low molecular weight band was not detected as a  band labeled by 
silver staining  in  purified preparations  of the antigen.  At  this  stage  no  clear 
conclusion can be made concerning the low molecular weight band. 
Discussion 
The  results  presented  establish  that  antibodies  against  the  CD4  (W3/25) 
antigen label a molecule on peritoneal rat macrophages that is indistinguishable 124  AUTHENTIC  CD4  (W3/25)  ANTIGEN  ON  MACROPHAGES 
FIGURE 5.  15% SDS-PAGE of [3SS]cysteine-labeled  purified peritoneal macrophages.  After 
labeling, cells were solubilized in  1% Nonidet P-40 and immunoprecipitated with MRC OX- 
21  (1), W3/25 (2), and MRC OX-27 (track 3). All samples were run nonreduced. 
from that on T  cells. This conclusion is reached because antibodies against two 
distinct epitopes on the CD4 (W3/25) antigen label macrophages from normal 
and athymic animals and because the antigen immunoprecipitated from deter- 
gent extracts of 125I-labeled  macrophages is  indistinguishable from the T  cell 
antigen. 
A second question is whether or not the macrophage CD4 (W3/25) antigen is 
an  endogenous product  or  might  be  acquired from T  cells.  There is  strong 
evidence for synthesis by macrophages from studies on athymic peritoneal cells 
that were labeled by W3/25 antibody in the same way as peritoneal cells from 
normal rats, even though athymic animals have few if any functional helper T 
cells (26). Attempts to show endogenous synthesis by biosynthetic labeling were 
only partially successful, in that weak labeling of the CD4 (W3/25) antigen band 
occurred when macrophages were incubated with [35S]cysteine  or [sSS]methio- 
nine. The CD4 (W3/25) antigen is a minor antigen on T  cells and macrophages, 
both of which bind -25,000  molecules of W3/25 antibody per cell (27 and W. 
Jefferies, unpublished results). The poor biosynthesis by macrophages was not 
due to a high percentage of the cells dying but could be due to low turnover of 
the  antigen  or  to  a  change  in  biosynthesis  in  culture.  Another  case  where 
biosynthesis does not correlate with surface antigen expression is that of mouse 
thymocytes, where major histocompatibility complex (MHC) antigens are major 
biosynthetic products even though they are expressed on only ~ 15% of the cells 
(28). Thus, in spite of weak biosynthetic labeling, we believe that the athymic rat 
data provide a  strong  case for endogenous synthesis,  in  accord with  data  on 
expression  of human  CD4  antigen.  In  a  study  by  Moscicki  et  al.  (13),  the 
molecular form  of human  macrophage CD4  antigen  was  not  established  but JEFFERIES, GREEN, AND WILLIAMS  125 
antibodies against distinct epitopes of CD4 labeled the cell line that was consid- 
ered to be of macrophage origin.  In this case, the antigen could not have been 
acquired from T  cells. 
Rat macrophages  from a  variety of tissues are  labeled by W3/25  antibody. 
Initially,  labeling of peritoneal,  spleen,  and  lymph node  macrophages  was re- 
ported (11); more recently (29), Kupffer cells in rat liver have been shown to be 
W3/25  positive.  Also,  cells  with  a  dendritic  morphology  in  sections of liver, 
heart,  and kidney were labeled with W3/25 antibody (29) and may be macro- 
phages or dendritic  cells of the  type described by Steinman  and  Nussenzweig 
(30).  At  least  50%  of monocytes from rat  blood have  also been  shown  to be 
labeled by W3/25 antibody (A. Robinson, personal communication). In humans, 
CD4 antigen  has been detected on macrophages in sections of intestine and on 
blood monocytes (12,  13). 
The CD4 antigen of T  helper cells is clearly implicated in the function of these 
cells in rat, man, and mouse, since anti-CD4 antibodies profoundly inhibit T  cell 
responses  to  antigen.  Furthermore,  it  has  been  established  (7,  8)  that  this 
inhibition  works at the level of T  cells rather  than  accessory cells.  It has been 
suggested that  the CD4 molecule functions to recognize class II MHC antigen 
on  antigen-presenting  cells  but  there  is  conflicting  evidence  (5,  9,  10,  31). 
Speculation on the function of the CD4 antigen has not taken into account the 
fact  that  it  is expressed on  macrophages and  possibly other accessory cells.  It 
remains to be established whether the CD4 molecule can be associated with any 
known macrophage function. 
Summary 
The  rat  W3/25  antigen  that  appears  to be equivalent  to  human  CD4  (T4) 
antigen  is expressed on  thymocytes and  T  helper cells and  plays a  role  in  the 
response of T  helper cells to antigen.  The  W3/25 and anti-T4 antibodies also 
label macrophages.  In this paper we examine whether the macrophage antigen 
is the same as that on T  cells. New monoclonal antibodies against the rat CD4 
antigen, MRC OX-35 through OX-38, are described, all of which label peritoneal 
macrophages from normal  and athymic rats.  The  molecular weight of W3/25 
antigen on macrophages is indistinguishable  from that on T  cells. We conclude 
that macrophages express authentic CD4 (W3/25) antigen. 
Another  new monoclonal  antibody,  MRC OX-34,  labels an  antigen  of 50- 
54,000 tool wt that  is expressed on rat T  but not B cells or peritoneal macro- 
phages.  It  was  used  to  control  for  the  presence  of any  T  cell  products  in 
immunoprecipitation  from rat macrophage extracts. 
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